Companies: 10,795·Total market cap: $144.5T
Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

AGN.CNCNQHealthcare
$0.05
+$0.00(+0.00%)
Market Cap$157523
P/E Ratio
52W High$1
52W Low$0.045
Overview

Algernon Pharmaceuticals Inc. (AGN.CN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AGN.CN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.62agn.cn eps ttm · agn.cn earnings per shareEarnings history
PE Ratio (TTM)agn.cn pe ratio ttm · agn.cn price to earningsPE Ratio deep dive
Revenue (TTM)0.00agn.cn revenue ttm · agn.cn annual revenueFull revenue history
Dividend YieldNo Dividenddoes agn.cn pay dividends · agn.cn dividend yieldDividend history
Shares Outstanding2.9Magn.cn shares outstanding · agn.cn floatShares outstanding history
Next EarningsTBAagn.cn earnings date · agn.cn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
algernon pharmaceuticals inc. revenue · agn.cn revenue 2025
FY 2025Net Income-$1.7M▼ 241.38% YoY
202320242025
algernon pharmaceuticals inc. net income · agn.cn profit 2025
FY 2025EPS$-0.58▼ 131.87% YoY
202320242025
agn.cn eps · algernon pharmaceuticals inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$1.9MEPS: $-0.62View income statement →

Stock Performance

Full History
1D-88.75%
1W-88.00%
1M-90.00%
3M-88.75%
YTD-92.50%
1Y-94.71%
5Y-99.89%

About Algernon Pharmaceuticals Inc.

CEOChristopher J. Moreau
IPO DateFeb 2, 2016
Employees5
CountryCA

Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company dedicated to discovering and developing new treatments. Their research and development efforts concentrate on a range of seriou…

what is algernon pharmaceuticals inc. · agn.cn stock overview · algernon pharmaceuticals inc. company profile · who is algernon pharmaceuticals inc. ceo · agn.cn CNQ · algernon pharmaceuticals inc. headquarters · algernon pharmaceuticals inc. business segments

About Stock Overview & Key Data

Algernon Pharmaceuticals Inc. (AGN.CN) is a Healthcare company in the Biotechnology industry, listed on CNQ since Feb 2, 2016. As of the latest trading session, AGN.CN stock price is $0.04, with a market capitalization of $157,523. The stock has returned -94.71% over the past 12 months and -92.50% year-to-date.

In fiscal year 2025, Algernon Pharmaceuticals Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Algernon Pharmaceuticals Inc. (AGN.CN) stock price is $0.04. The stock is traded on CNQ under the ticker symbol AGN.CN. The 52-week range is $0.04 – $1.00.

AGN.CN stock priceAGN.CN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice